CytomX regains Nasdaq minimum bid price compliance as of May 23, 2025

CytomX Therapeutics, Inc.

Nasdaq Staff notified company on May 27, 2025, of compliance regained.
Closing price ≥ $1.00 for 10 consecutive trading days ended May 23, 2025.
Resolves previous deficiency notice from February 24, 2025.
Matter is now closed with no further action required.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.